We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 6,739 results
  1. Comparative pharmacokinetic investigation on crocetin in hyperlipidemia and normal rats after oral administration

    Crocetin as one of the main components of saffron possesses a lot of pharmacological effects, especially the beneficial effects in the treatment of...

    Cheng-Ye She, Yuan-**ong Deng, ... **g Li in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 22 February 2024
  2. Identification of Central Genes and Regulatory Pathways Associated with Hyperlipidemia in Rats

    Hyperlipidemia is an independent risk factor for cardiovascular and cerebrovascular diseases. The transcriptomic data and the gene regulatory...

    **nyue Fu, **nni Song, ... Wanfu Bai in Biochemical Genetics
    Article 13 February 2024
  3. Hyperlipidemia in tendon injury: chronicles of low-density lipoproteins

    Hyperlipidemia impacts millions of people globally and has been the major risk factor for develo** atherosclerosis and cardiovascular disease....

    William H. Fang, Victor Bonavida, ... Finosh G. Thankam in Cell and Tissue Research
    Article Open access 04 February 2023
  4. A novel small-molecule PCSK9 inhibitor E28362 ameliorates hyperlipidemia and atherosclerosis

    Proprotein convertase subtilisin/kexin type 9 (PCSK9) binds to the epidermal growth factor precursor homologous domain A (EGF-A) of low-density...

    Wei-zhi Wang, Chao Liu, ... Shu-yi Si in Acta Pharmacologica Sinica
    Article 29 May 2024
  5. A novel mouse model of familial combined hyperlipidemia and atherosclerosis

    Within the context of residual cardiovascular risk in post-statin era, emerging evidence from epidemiologic and human genetic studies have...

    Mei-jie Chen, Yi-tong Xu, ... Suo-wen Xu in Acta Pharmacologica Sinica
    Article 08 March 2024
  6. Pharmacodynamic Studies of Pravastatin Sodium Nanoemulsion Loaded Transdermal Patch for Treatment of Hyperlipidemia

    Pravastatin sodium (PVS) is a hypolipidemic drug with poor oral bioavailability due to the first-pass effect. Therefore, this study aims to formulate...

    Seham I Elsayed, Marwa S El-Dahan, Germeen N. S Girgis in AAPS PharmSciTech
    Article Open access 08 February 2024
  7. Integrative regulation of hLMR1 by dietary and genetic factors in nonalcoholic fatty liver disease and hyperlipidemia

    Long non-coding RNA (lncRNA) genes represent a large class of transcripts that are widely expressed across species. As most human lncRNAs are...

    Marcos E Jaso-Vera, Shohei Takaoka, ... **angbo Ruan in Human Genetics
    Article 17 March 2024
  8. Hypolipidemic effect of ethanol extract from Chimonanthus nitens Oliv. leaves in hyperlipidemia rats via activation of the leptin/JAK2/STAT3 pathway

    Background

    This study aims to explore the protective role of ethanol extract from Chimonanthus nitens Oliv. leaf (COE) in hyperlipidemia via the...

    Jian** Pan, ** Zheng in Molecular Medicine
    Article Open access 20 December 2022
  9. Role of Hypertension and Hyperlipidemia in the Pathogenesis of Dementia

    Dementia is not a single ailment, but a term that describes symptoms of impairment in memory, communication, and thinking, which occurs mainly in the...
    Meenakshi Kaira, Vaibhav Walia, Munish Garg in Current Thoughts on Dementia
    Chapter 2022
  10. Asprosin Exacerbates Endothelium Inflammation Induced by Hyperlipidemia Through Activating IKKβ-NF-κBp65 Pathway

    Vascular endothelium dysfunction caused by endothelium inflammation is a trigger of numerous cardiovascular diseases. Vascular endothelium...

    Qianqian Huang, Sheng Chen, ... Qiren Huang in Inflammation
    Article 19 November 2022
  11. A common variant in 11q23.3 associated with hyperlipidemia is mediated by the binding and regulation of GATA4

    Large-scale genome-wide associations comprising multiple studies have identified hundreds of genetic loci commonly associated with...

    Wen-Cheng Chou, Wei-Ting Chen, Chen-Yang Shen in npj Genomic Medicine
    Article Open access 19 January 2022
  12. Genetics of Familial Combined Hyperlipidemia (FCHL) Disorder: An Update

    Familial combined hyperlipidemia (FCHL) is one of the most common familial lipoprotein disorders of the lipoproteins, with a prevalence of 0.5% to 2%...

    Eskandar Taghizadeh, Najmeh Farahani, ... Seyed Mohammad Gheibihayat in Biochemical Genetics
    Article 03 September 2021
  13. Integrated lipidomics and network pharmacology analysis to reveal the mechanisms of berberine in the treatment of hyperlipidemia

    Background

    Berberine (BBR), an isoquinoline alkaloid isolated from Rhizoma Coptis, is widely used in the treatment of hyperlipidemia (HLP) in China....

    Yuting Chen, Kaipeng Li, ... Ding Zhao in Journal of Translational Medicine
    Article Open access 08 September 2022
  14. Observation of Skin Color Change by Carotenosis in Hyperlipidemia Patient

    Purpose

    In this study, we focus on the relationship between carotenosis and hyperlipidemia. Because carotenoids are lipophilic, they are more soluble...

    Article 17 May 2021
  15. Exercise and Hyperlipidemia

    Hyperlipidemia is one of the common pathological conditions of human, which occurs due to lipid metabolism disorder in the human body, resulting in...
    Nana He, Honghua Ye in Physical Exercise for Human Health
    Chapter 2020
  16. Prevalence and associated factors of uncontrolled hyperlipidemia among Thai patients with diabetes and clinical atherosclerotic cardiovascular diseases: a cross-sectional study

    Objectives

    The research aimed to determine the prevalence and associated factors of uncontrolled hyperlipidemia among Thai patients with the disease...

    Teeraboon Lertwanichwattana, Ram Rangsin, Boonsub Sakboonyarat in BMC Research Notes
    Article Open access 25 March 2021
  17. Autophagy, Hyperlipidemia, and Atherosclerosis

    Autophagy is an evolutionarily conserved process in eukaryotes that processes the turnover of intracellular substances. Atherosclerosis is a disease...
    Junying Miao, **aoling Zang, ... Jun Zhang in Autophagy: Biology and Diseases
    Chapter 2020
  18. Role of Synbiotics in Metabolic Disorders

    Metabolic disorders have reached epidemic proportions worldwide, making them one of the twenty-first century’s most serious public health issues. The...
    Gurmeet Singh, Simran Deep Kaur, ... Amandeep Singh in Synbiotics in Human Health: Biology to Drug Delivery
    Reference work entry 2024
  19. High fat diet induces brain injury and neuronal apoptosis via down-regulating 3-β hydroxycholesterol 24 reductase (DHCR24)

    Hyperlipidemia (HLP) is one of the risk factors for memory impairment and cognitive impairment. However, its pathological molecular mechanism...

    Ziyin Lu, Haozhen Wang, ... Bing Gao in Cell and Tissue Research
    Article 17 July 2023
  20. Effects of risk factors on the development and mortality of early- and late-onset dementia: an 11-year longitudinal nationwide population-based cohort study in South Korea

    Background

    Early-onset dementia (EOD, onset age < 65) and late-onset dementia (LOD, onset age ≥ 65) exhibit distinct features. Understanding the risk...

    Min Young Chun, Wonjeong Chae, ... Hee ** Kim in Alzheimer's Research & Therapy
    Article Open access 25 April 2024
Did you find what you were looking for? Share feedback.